Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.